U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07159594) titled 'The Impact of a Weight Reduction Intervention on Clinical Outcomes in Patients With Obesity and COPD' on Aug. 28.
Brief Summary: Obesity and COPD are increasingly common and often coexist, worsening health outcomes such as reduced lung function, exercise capacity, and increased systemic inflammation. While COPD was historically associated with underweight, obesity is now more prevalent among these patients and poses new challenges. Despite some evidence that weight loss may improve lung function, comprehensive interventions have not been fully studied.
The TRIO-COPD study aims to evaluate a 20-week program combining energy restrict...